We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Enzyme Discovered May Lead to Better TB Test

By LabMedica International staff writers
Posted on 31 Jan 2013
An enzyme has been identified that will trigger the rapid breakdown of several Mycobacteria, which could lead to better tests for the deadly tuberculosis infection.

The current bacterial culture test for tuberculosis infections is highly accurate but time-consuming, taking up to several weeks, while the diagnostic process called nucleic acid-based amplification (NAA) faces difficulty in breaking open, or lysing bacteria. More...


Scientists at University of Pittsburgh Graduate School of Public Health (PA, USA) show that exposure to an enzyme called esterase from Mycobacterium smegmatis hydrolyzes the ester linkage of trehalose dimycolate in vitro, which triggers the rapid and efficient lysis of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium marinum.

A rapid and efficient lysis of trehalose dimycolate hydrolase (TDMH) exposed M. tuberculosis, and a subsequent release of nucleic acids (NA) offered a unique opportunity to use this enzyme for achieving more sensitive detection in a nucleic acid amplification assay for the diagnosis of tuberculosis (TB). The nucleic content in the supernatant of TDMH-exposed bacilli started to increase within 30 minutes of exposure, and it peaked at around 60 minutes.

Treatment of samples with TDMH prior to the amplification reaction facilitated the NA detection in 37 samples, a highly significant improvement in the numbers of positive detection. The investigators also demonstrated that this quick lysis of M. tuberculosis improved its detection at lower density.

Anil Ojha, PhD, an assistant professor and senior author of the study said, "Tuberculosis is a huge public health burden. Clearly, controlling the infection is heavily dependent upon an effective diagnosis. Discovery of enzyme-based mycobacteria lysis has the potential to increase the sensitivity of NAA." The study was published on January 4, 2013, in the Journal of Biological Chemistry.

Related Links:
University of Pittsburgh


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.